Advances in local drug release and scaffolding design to enhance cell therapy for diabetes
DT Bowers, EA Botchwey… - Tissue Engineering Part B …, 2015 - liebertpub.com
Islet transplant is a curative treatment for insulin-dependent diabetes. However, challenges,
including poor tissue survival and a lack of efficient engraftment, must be overcome. An …
including poor tissue survival and a lack of efficient engraftment, must be overcome. An …
Advances in Local Drug Release and Scaffolding Design to Enhance Cell Therapy for Diabetes
DT Bowers, EA Botchwey… - … engineering. Part B …, 2015 - pubmed.ncbi.nlm.nih.gov
Islet transplant is a curative treatment for insulin-dependent diabetes. However, challenges,
including poor tissue survival and a lack of efficient engraftment, must be overcome. An …
including poor tissue survival and a lack of efficient engraftment, must be overcome. An …
Advances in Local Drug Release and Scaffolding Design to Enhance Cell Therapy for Diabetes
DT Bowers, EA Botchwey… - Tissue Engineering Part …, 2015 - search.proquest.com
Islet transplant is a curative treatment for insulin-dependent diabetes. However, challenges,
including poor tissue survival and a lack of efficient engraftment, must be overcome. An …
including poor tissue survival and a lack of efficient engraftment, must be overcome. An …
Advances in Local Drug Release and Scaffolding Design to Enhance Cell Therapy for Diabetes.
DT Bowers, EA Botchwey… - Tissue engineering. Part B …, 2015 - europepmc.org
Islet transplant is a curative treatment for insulin-dependent diabetes. However, challenges,
including poor tissue survival and a lack of efficient engraftment, must be overcome. An …
including poor tissue survival and a lack of efficient engraftment, must be overcome. An …